Machicado C. auteur aut IRD Bertani Stéphane auteur aut IRD Herrera-Velit P. auteur aut IRD Espinoza J. auteur aut IRD Ruiz E. auteur aut IRD Marcos L. auteur aut IRD text journalArticle eng text/pdf reformatted digital access Introduction: The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with HCC. This study aimed to determine the existence of specific IgG antibodies against F. hepatica in the serum samples of HCC patients. Methods: In total, 13 scrum samples from 13 HCC patients were screened using Fas2-ELISA. Results: Fas2-ELISA demonstrated negative results in all HCC patients included in this study. Conclusions: The pre-existence of F hepatica infection in HCC patients needs to be further investigated in epidemiological and experimental studies. specialized Cholangiocarcinoma Fasciolosis Fibrosis Hepatocellular carcinoma Liver fluke PEROU 052 050 51 2 231-233 2018 0037-8682 https://www.documentation.ird.fr/hor/fdi:010073026 10.1590/0037-8682-0180-2017 0037-8682 [F B010073026] https://www.documentation.ird.fr/hor/fdi:010073026 https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers18-06/010073026.pdf IRD - Base Horizon / Pleins textes 2018-07-03 2023-07-11 fdi:010073026 fre